Sign In
Buy ENTX
$1.22
-0.0300 (-2.40%)
At Close: Jun 03, 2026
Entera (ENTX) Up on Positive Results From Osteoporosis Drug
01:32pm, Thursday, 24'th Jun 2021
Entera (ENTX) gains on positive results from a mid-stage study on its osteoporosis candidate at six months.
Where Might Entera Bio Stock End Up After Rallying Wednesday
03:40pm, Wednesday, 23'rd Jun 2021
Entera Bio Ltd (NASDAQ: ENTX) shares rallied higher Wednesday after the company announced it saw positive results from its final six-month bone mineral density results from the completed Phase 2 clin
ENTX Stock: The Huge FDA News Sending Entera Bio Soaring
03:17pm, Wednesday, 23'rd Jun 2021
Today, investors in ENTX stock are seeing gains of approximately 40% as the company announced results from one of its clinical trials. The post ENTX Stock: The Huge FDA News Sending Entera Bio Soaring
Options Traders Bombard ENTX After Drug Update
02:30pm, Wednesday, 23'rd Jun 2021
The shares of Entera Bio Ltd.
Why Entera Bio, Orphazyme, Bellerophon Are Moving Today
01:22pm, Wednesday, 23'rd Jun 2021
Entera Bio Ltd. (NASDAQ: ENTX), Orphazyme A/S (NASDAQ: ORPH) and Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) are among the biggest biopharma movers Wednesday.
Why Entera Bio Shares Are Skyrocketing Today
12:15pm, Wednesday, 23'rd Jun 2021
Entera Bio Ltd (NASDAQ: ENTX) shares are trading higher by 47.66% at $6.63 Wednesday after the company announced the topline Phase 2 clinical trial of EB613 met its primary and key secondary endpoint
8 Hot Biotech Penny Stocks For Your July 2021 Watch List
11:27am, Wednesday, 23'rd Jun 2021
Current & Former Penny Stocks To Watch Before July The post 8 Hot Biotech Penny Stocks For Your July 2021 Watch List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.co
Entera Bio Announces Excellent Topline Phase 2 BMD Data for EB613, the Study Met Its Primary and Key Secondary Endpoints
08:30am, Wednesday, 23'rd Jun 2021
BOSTON and JERUSALEM, June 23, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule and biologic therapeutics, announced the final 6-
Entera Bio (ENTX) is Overbought: Is A Drop Coming?
07:32am, Friday, 18'th Jun 2021
Entera Bio (ENTX) has moved higher as of late, but there could definitely be trouble on the horizon for this company.
Entera Bio Reports First Quarter 2021 Financial Results and Provides Clinical Updates
08:00am, Thursday, 20'th May 2021
‒ Phase 2 EB613 Clinical Trial in Osteoporosis Achieves 3-Month Primary Endpoint; Final Data Including BMD Expected Q2:21 ‒
Here's Why Entera Bio (ENTX) Stock Has Almost Tripled This Year
09:46am, Wednesday, 19'th May 2021
Entera Bio's (ENTX) stock price is being driven by encouraging data from phase II study on EB613, its investigational orally delivered treatment for osteoporosis
Entera Announces Ron Mayron, a Global Pharma Leader, Joins its Board of Directors
08:45am, Tuesday, 20'th Apr 2021
BOSTON and JERUSALEM, April 20, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, today announced that Ron Mayron ha
Entera Appoints Ramesh Ratan as Chief Financial Officer
08:30am, Thursday, 15'th Apr 2021
BOSTON and JERUSALEM, Israel, April 15, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, today announced the appo
New Data Suggest Entera's Platform Orally Delivers Human Growth Hormone, Study Results to be Presented at European Pharma Congress
08:30am, Tuesday, 06'th Apr 2021
BOSTON and JERUSALEM, April 06, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of orally delivered large molecule therapeutics, today announced the Company will d
Entera Bio's (ENTX) CEO Spiros Jamas on Q4 2020 Results - Earnings Call Transcript
01:19pm, Thursday, 18'th Mar 2021
Entera Bio's (ENTX) CEO Spiros Jamas on Q4 2020 Results - Earnings Call Transcript
